CanSino Biologics on AstraZeneca Deal, Earnings
Xuefeng Yu, Chairman, Co-Founder & CEO at CanSino Biologics, discusses collaboration plans with pharmaceutical companies including AstraZeneca as well as the company's first half results. He speaks with Rishaad Salamat, David Ingles and Yvonne Man on "Bloomberg Markets Asia". (Source: Bloomberg) #press
